U.S. probes deaths for links to Monster energy drink

Two cans of Monster Energy drink are pictured in this photo-illustration shot in Los AngelesNEW YORK/WASHINGTON (Reuters) – The Food and Drug Administration said on Monday that it was investigating reports of five deaths that may be associated with Monster Beverage Corp's namesake energy drink, and the company's shares fell more than 14 percent. Monster is also being sued by the family of a 14-year-old Maryland girl with a heart condition who died after drinking two cans of its Monster energy drink in a 24-hour period. Monster, the top-selling energy drink in the United States, said it does not believe its energy drink was "in any way responsible" for the girl's death. …

Syria says sanctions hurting its children

UNITED NATIONS (Reuters) – Sanctions imposed on Syria by the European Union, the United States and others over its 19-month conflict are “immoral and illegal” and harming Syrian children, the government wrote in a letter to U.N. Secretary-General Ban Ki-moon released on Monday. The letter from the Syrian government was in response to a recent report by Leila Zerrougui, Ban’s special representative for children and armed conflict, who accused both sides in Syria of targeting children with bomb attacks, sexual violence and torture. …

California city seeks to cut asthma rate via bond issue

NEW YORK (Reuters) – The city of Fresno, Calif., will be the first municipality in the United States to see whether “social impact bonds,” an innovative security that promotes a societal benefit, can be used to tackle a major healthcare problem like asthma. Fresno is using this new pay-for-success model, which will reward investors providing the financing for the program, if incidents of chronic asthma are reduced in this community where 20 percent of the city’s population suffers from the ailment, compared to 8 percent nationally, according to a California Health Interview Survey. …

Novo Nordisk wins EU agency backing for new insulin

LONDON/COPENHAGEN (Reuters) – Novo Nordisk’s ultra long-acting insulin Tresiba has been recommended for approval by the European Medicines Agency in an important boost for the Danish drugmaker’s key new product. The European endorsement, announced by the London-based agency and the company on Friday, follows regulatory delays for the diabetes treatment in the United States, where the bulk of future sales are expected to be generated. …

Analysis links psoriasis, diabetes

NEW YORK (Reuters Health) – A new review of more than two dozen studies adds support to the link between the chronic skin disease psoriasis and diabetes. In studies from the United States, Europe, the Middle East and elsewhere, participants with psoriasis had anywhere from an equal risk to an almost four-fold higher risk of developing diabetes than those without the skin condition. According to the National Institutes of Health, more than three percent of adults in the U.S. have psoriasis, which is characterized by itchy, painful plaques on the skin. …

FDA advisers back NPS’s drug for short bowel syndrome

(Reuters) – U.S. drug advisers on Tuesday backed a drug to treat a rare and serious bowel disorder for which there is no long-term treatment available in the United States. A panel of outside advisers to the U.S. Food and Drug Administration agreed that NPS Pharmaceuticals Inc had demonstrated that the drug is safe and improves absorption of fluid and nutrients in the intestines of adults with short bowel syndrome. The 12-member panel voted unanimously in the drug’s favor. The FDA usually follows the advice of expert panels. …

GlaxoSmithKline to reveal more drug secrets

LONDON (Reuters) – GlaxoSmithKline, criticized in the past for keeping important information about its medicines to itself, is to lift the lid on more of its drug secrets. Three months after GSK was fined $3 billion for fraud in the United States, where prosecutors accused it of concealing safety issues, chief executive Andrew Witty said on Thursday detailed data from its clinical trials would be made available to other researchers. That would include anonymised patient-level results that sit behind clinical trials of approved and failed drugs. …

West Nile outbreak closer to being second worst in U.S

DALLAS (Reuters) – The outbreak of West Nile disease in the United States moved a step closer on Wednesday to becoming the second worst on record with federal health authorities reporting 280 cases of the virus-caused illness over the past week. There have now been 4,249 cases of West Nile recorded this year, according to the Centers for Disease Control and Prevention, 20 cases fewer than in 2006, the second-largest outbreak on record. The number of deaths rose by five to 168 since last week, the CDC said. …

1 2 3 4 5 6 25